Depression - Health Rising

Did a Lab Study Just Uncover a Craniocervical Instability Subset in ME/CFS?

Tackling Pain and Depression in Fibromyalgia: Quetiapine Scores Some Benefits in Clinical Trial

by Cort Johnson | Feb 27, 2014 | Depression, Drugs, Quetiapine

Quetiapine took on a groups of severely afflicted fibromyalgia patients with both pain and depression. How did it do? Check it out here.

Subscribe To Health Rising’s Free Chronic Fatigue Syndrome, Fibromyalgia and Long COVID Information

Support Health Rising

HEALTH RISING IS NOT A 501 (c) 3 NON-PROFIT

Lives Interrupted

Lives Interrupted Latest Story

Entire Adulthood taken from me

Megan

Randolph, United States

Former occupation: Day care worker

Total Economic Losses:

$562,824

Lives Interrupted Stats

Number of Stories: 46

Years of Work Lost: 347

Average Total Economic Losses:

$873,188

Total Economic Losses:

$28,815,211

StudyME

Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.

Find out more here

Enroll here

Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News

Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.

Did a Lab Study Just Uncover a Craniocervical Instability Subset in ME/CFS?

Tackling Pain and Depression in Fibromyalgia: Quetiapine Scores Some Benefits in Clinical Trial

Subscribe

Support Health Rising

Lives Interrupted

Lives Interrupted Latest Story

Lives Interrupted Stats

StudyME

Simmaron Research

ME/CFS & Fibromyalgia Treatment Room

May 12th - International ME/CFS & FM Awareness Day

Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News

Thank you for signing up!

Pin It on Pinterest